Recent Posts
Connect with:
Tuesday / May 21.
HomemieducationDrought Breaker: New GA Treatments to Impact Optometry

Drought Breaker: New GA Treatments to Impact Optometry

1.25T hours with Assessment – Optometry Australia IoE Quality Assurance | TBC in New Zealand

One of the defining moments in ophthalmology was the introduction of intravitreal anti-VEGFs to treat neovascular age-related macular degeneration (nAMD). Now, eye care professionals outside the United States await news from their respective regulatory bodies about the approval of the newest intravitreal injection (IVI) agents, pegcetacoplan and avacincaptad pegol. Given the green light by the United States Food and Drug Administration (FDA) last year, these drugs represent the first-ever treatments for geographic atrophy (GA) – and the first real hope for clinicians and patients alike. So, what would a post-approval patient pathway look like, and how can we manage their expectations?…Read and take test.